Chongqing targets 10 new innovative drugs and devices by 2030

Chongqing's plan signals that China's innovation push is being operationalized at the municipal level, with approval targets now embedded in local government planning alongside inspection benchmarks. For drugmakers and device developers with regional ties, the plan's mix of quality thresholds and innovation quotas suggests a compliance-plus-innovation framework rather than a purely volume-driven one. Whether the 15 targets translate into actual approvals — and how the 28 tasks are sequenced — is the open question worth tracking as implementation details emerge.